Related Experiment Video
Updated: Sep 27, 2025

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
Published on: March 21, 2021
Thoracic sarcopenia predicts clinical outcomes in patients undergoing coronary artery bypass grafting: A 6-year
Zi-Le Shen1, Zhang Liu2, Wang-Fu Zang2
1Department of Gastrointestinal Surgery, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Insights
Thoracic sarcopenia, a measure of muscle loss in the chest, predicts worse outcomes after coronary artery bypass grafting (CABG). Identifying this condition aids in preoperative risk assessment for better patient care.
Area of Science:
- Cardiology
- Thoracic Surgery
- Geriatrics
Background:
- The prognostic impact of thoracic sarcopenia on clinical outcomes following coronary artery bypass grafting (CABG) remains inadequately defined.
- This study investigates the predictive value of thoracic sarcopenia for adverse events in CABG patients.
Purpose of the Study:
- To assess the prognostic significance of thoracic sarcopenia in patients undergoing CABG.
- To determine if thoracic sarcopenia is associated with increased postoperative complications and reduced overall survival.
Main Methods:
- A cohort of 338 patients undergoing isolated CABG between December 2015 and May 2021 was analyzed.
- Thoracic sarcopenia was assessed using skeletal muscle area at the T12 level, normalized from chest computed tomography (CT) scans.
- Univariate and multivariate analyses were employed to identify risk factors for postoperative complications and overall survival (OS).
Main Results:
- The prevalence of thoracic sarcopenia was 13.02% among the studied CABG patients.
- Patients with thoracic sarcopenia exhibited significantly higher rates of major complications (81.8% vs. 61.9%), longer hospital and ICU stays, increased costs, and higher 30-day readmission rates.
- Thoracic sarcopenia was independently associated with adverse postoperative complications and diminished long-term OS (2-year survival: 72.7% vs. 93.9% in non-sarcopenic patients).
Conclusions:
- Thoracic sarcopenia serves as a robust clinical predictor for adverse postoperative complications and long-term overall survival in patients after CABG.
- Incorporating thoracic sarcopenia assessment via chest CT into preoperative risk stratification for CABG is recommended.
Background:
The relationship between thoracic sarcopenia and clinical outcomes in patients underwent coronary artery bypass grafting (CABG) is unclear. This study aims to evaluate whether thoracic sarcopenia has a satisfactory prognostic effect on adverse outcomes after CABG.
Methods:
From December 2015 to May 2021, 338 patients who underwent isolated CABG at our institution were recruited in this study. Skeletal muscle area at T12 level acquired by chest computed tomography (CT) was normalized to assess thoracic sarcopenia. Univariate and multivariate analyses were performed to evaluate the risk factors of postoperative complications and overall survival (OS).
Results:
The prevalence of thoracic sarcopenia in patients underwent CABG was 13.02%. The incidence of total major complication was significantly higher in thoracic sarcopenia group (81.8% vs 61.9%, p = 0.010). Thoracic sarcopenic patients also had longer postoperative hospital stays (p = 0.047), intensive care unit (ICU) stays (p = 0.001), higher costs (p = 0.001) and readmission rates within 30 days of discharge (18.2% vs 4.4%, p = 0.001). Patients without thoracic sarcopenia showed significantly higher OS at the 2-year follow-up period (93.9% vs 72.7%, p<0.001). Multivariate analyses demonstrated that thoracic sarcopenia was significantly and independently associated with postoperative complications and long-term OS after CABG.
Conclusion:
Thoracic sarcopenia is an effective clinical predictor of adverse postoperative complications and long-term OS in patients underwent CABG. Thoracic sarcopenia based on chest CT should be included in preoperative risk assessment of CABG.
Related Concept Videos
Thoracic Aorta
Coronary Artery Disease III: Clinical Manifestations
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies

